/Companies

Atia Vision

Campbell, US · 5 known investors

Find your way into Atia Vision

Sign up to see every warm intro you have to Atia Vision

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Atia Vision team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Atia Vision develops OmniVu, a modular shape-changing dual-optic intraocular lens (IOL) that uses the eye's natural accommodative mechanism to restore near, intermediate, and distance vision for cataract patients. The device is investigational and not yet available for sale.

Founders & leadership

HC
Henry ChenNamed on SEC filing
CA
Claudio ArgentoNamed on SEC filing
MM
Mariam MaghribiNamed on SEC filing
AS
Amr SalahiehNamed on SEC filing
CG
Casey GordonNamed on SEC filing

Investors · 5

Funding

SEC filings, press & company announcements

$71M disclosed across 6 rounds · 2018–2022

▶$28.6MraisedAug 2022 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bihua ChenDirector
  • Claudio ArgentoDirector
  • Mariam MaghribiExecutive Officer, Director
  • Casey GordonDirector
  • Amr SalahiehDirector
Offering amount
$28.6M
Amount sold
$28.6M
Minimum investment
$15K
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.4MraisedNov 2021 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bihua ChenDirector
  • Casey GordonDirector
  • Amr SalahiehDirector
  • Mariam MaghribiExecutive Officer, Director
  • Claudio ArgentoDirector
Offering amount
$6.5M
Amount sold
$5.4M
Minimum investment
$31K
First sale
Nov 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.6MraisedMay 2019 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mariam MaghribiExecutive Officer, Director
  • Amr SalahiehDirector
  • Bihua ChenDirector
  • Casey GordonDirector
  • Claudio ArgentoDirector
Offering amount
$20M
Amount sold
$11.6M
Minimum investment
$25K
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.3MraisedNov 2018 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Casey GordonDirector
  • Mariam MaghribiExecutive Officer, Director
  • Claudio ArgentoDirector
  • Henry ChenDirector
  • Amr SalahiehDirector
Offering amount
$3.3M
Amount sold
$3.3M
First sale
Nov 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedApr 2018 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Henry ChenDirector
  • Claudio ArgentoDirector
  • Mariam MaghribiExecutive Officer, Director
  • Amr SalahiehDirector
  • Casey GordonDirector
Offering amount
$2M
Amount sold
$2M
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Atia Vision do?
Atia Vision develops OmniVu, a modular shape-changing dual-optic intraocular lens (IOL) that uses the eye's natural accommodative mechanism to restore near, intermediate, and distance vision for cataract patients. The device is investigational and not yet available for sale.
Who are Atia Vision's investors?
Atia Vision's investors include Amed Ventures, The Capital Partnership, Delos Capital, Rising Tide, ShangBay Capital LLC.
How much funding has Atia Vision raised?
Atia Vision has disclosed $71M raised across 6 rounds.
Where is Atia Vision headquartered?
Atia Vision is headquartered in Campbell, US.